Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Antidepressants are considered driving-impairing medicines (DIM). This is a population-based registry study that shows the trend in the use of antidepressants in Castile and León, Spain, from 2015 to 2018. Data on antidepressant dispensations at pharmacies and the adjusted use of these medicines by the driver population are presented. For the purposes of analysis, population distribution by age and gender has been taken into account, as well as the three Driving Under the Influence of Drugs, alcohol, and medicines (DRUID) categories. Antidepressants were used by 8.56% of the general population and 5.66% of drivers. Antidepressants were used more commonly by females than by males (12.12% vs. 4.87%, χ² = 1325.124, p = 0.001), and users increased as the age increased, even if women who drive used less antidepressants after turning 60 years of age. Chronic use of antidepressants was relevant (8.28%) in the same way as daily use (3.15%). Most of the consumption included SSRIs (4.99%), which are also known as “other antidepressants” (3.71%). Regardless of antidepressants consumed, users took 2.75 ± 1.19 DIMs, which are mainly anxiolytics (58.80%) and opioids (26.43%). Lastly, regarding consumption of antidepressants according to the DRUID classification, category I predominated over categories II and III. Our findings should serve as a starting point for health and traffic authorities to raise awareness of the risk for traffic accidents, especially involving SSRIs.
Antidepressants are considered driving-impairing medicines (DIM). This is a population-based registry study that shows the trend in the use of antidepressants in Castile and León, Spain, from 2015 to 2018. Data on antidepressant dispensations at pharmacies and the adjusted use of these medicines by the driver population are presented. For the purposes of analysis, population distribution by age and gender has been taken into account, as well as the three Driving Under the Influence of Drugs, alcohol, and medicines (DRUID) categories. Antidepressants were used by 8.56% of the general population and 5.66% of drivers. Antidepressants were used more commonly by females than by males (12.12% vs. 4.87%, χ² = 1325.124, p = 0.001), and users increased as the age increased, even if women who drive used less antidepressants after turning 60 years of age. Chronic use of antidepressants was relevant (8.28%) in the same way as daily use (3.15%). Most of the consumption included SSRIs (4.99%), which are also known as “other antidepressants” (3.71%). Regardless of antidepressants consumed, users took 2.75 ± 1.19 DIMs, which are mainly anxiolytics (58.80%) and opioids (26.43%). Lastly, regarding consumption of antidepressants according to the DRUID classification, category I predominated over categories II and III. Our findings should serve as a starting point for health and traffic authorities to raise awareness of the risk for traffic accidents, especially involving SSRIs.
Stigma towards psychological problems is an ongoing issue that negatively affects people living with these circumstances, diminishing their quality of life and well-being. This stigma can even aggravate the symptomatology itself and hinder the recovery process (Corrigan et al., 2012;Del Rosal et al., 2020;Livingston & Boyd, 2010).The Mental Illness Stigma Framework (MISF) (Fox et al., 2018) conceptualises stigma towards mental health problems from two perspectives: that of the person who stigmatises and that of the stigmatised person. The conceptual cores of the stigmatiser, which make up social stigma, refer to stereotypes (cognitive dimension), prejudice (affective dimension), and discrimination (behavioural dimension) (Corrigan & Watson, 2002). Therefore, social stigma occurs when the general population, based on their shared beliefs about the illness and the negative emotions it generates, acts in a discriminatory manner towards people with psychological problems. From the perspective of the stigmatised person, meanwhile, there is internalised stigma, resulting from the internalisation and selfapplication of these prejudices and stereotypes, as well as from the discriminatory experiences lived (Livingston & Boyd, 2010). Finally, as a common element in both prisms, there is structural stigma, which limits the opportunities of people with psychological problems at institutional, political and legal levels (Fox et al., 2018).
The study investigated personal attributes, the level of awareness about mental health and depression, and the self-perception regarding self-stigma and public stigma in Barangay Alawihao, Daet, Camarines Sur. It also uncovers the respondent's level of awareness about mental health and depression topics and self-perception of self-stigma and public stigma. In addition, it also proposed and recommended activities to disseminate awareness of depression. The study utilized a descriptive qualitative research design with 100 respondents. Data collected were collated and analyzed through descriptive statistics using frequency count, percentage technique, and weighted mean. The findings revealed that the respondents are young adults, with the majority of female college undergraduates displaying a commendable awareness level regarding mental health and depression. Suggested seminars and leaflets are effective tools for disseminating relevant information on mental health, depression, and stigma. With this, it is recommended to conduct further studies using different variables, continuing to raise awareness about mental health causes, organizing seminar series, and distributing leaflets to combat self-stigma and public stigma on depression. Additionally, the study suggests crafting a proposal for conducting seminars and creating and distributing leaflets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.